User profiles for Victor J Gallardo
 | Víctor J. Gallardo (ORCID: 0000-0002-3042-2007)VHIR Verified email at vhir.org Cited by 892 |
Post-COVID-19 persistent headache: a multicentric 9-months follow-up study of 905 patients
…, J Díaz-de-Terán, VJ Gallardo… - …, 2022 - journals.sagepub.com
Background Headache is a frequent symptoms of coronavirus disease 2019 (COVID-19). Its
long-term evolution remains unknown. We aim to evaluate the long-term duration of …
long-term evolution remains unknown. We aim to evaluate the long-term duration of …
The relationship of headache as a symptom to COVID‐19 survival: A systematic review and meta‐analysis of survival of 43,169 inpatients with COVID‐19
VJ Gallardo, RE Shapiro, E Caronna… - … : The Journal of …, 2022 - Wiley Online Library
Objective To study the relationship between coronavirus disease 2019 (COVID‐19) mortality
and headache among patients evaluated for COVID‐19 in Emergency Departments and …
and headache among patients evaluated for COVID‐19 in Emergency Departments and …
Salivary CGRP and erenumab treatment response: towards precision medicine in migraine
A Alpuente, VJ Gallardo, L Asskour… - Annals of …, 2022 - Wiley Online Library
Objective We aimed (1) to analyze salivary calcitonin gene‐related peptide (CGRP) levels in
patients with migraine, (2) to predict erenumab response from baseline CGRP levels, and (3…
patients with migraine, (2) to predict erenumab response from baseline CGRP levels, and (3…
The impact of anti-CGRP monoclonal antibodies in resistant migraine patients: a real-world evidence observational study
M Torres-Ferrús, VJ Gallardo, A Alpuente… - Journal of …, 2021 - Springer
Objective To evaluate the frequency and headache-related impact response to monoclonal
antibodies against calcitonin gene-related peptide (CGRP) in a clinical sample of refractory …
antibodies against calcitonin gene-related peptide (CGRP) in a clinical sample of refractory …
Cluster Headache Genomewide Association Study and Meta‐Analysis Identifies Eight Loci and Implicates Smoking as Causal Risk Factor
…, I Callesen, T Kelderman, VJ Gallardo… - Annals of …, 2023 - Wiley Online Library
Objective The objective of this study was to aggregate data for the first genomewide
association study meta‐analysis of cluster headache, to identify genetic risk variants, and gain …
association study meta‐analysis of cluster headache, to identify genetic risk variants, and gain …
Salivary CGRP can monitor the different migraine phases: CGRP (in) dependent attacks
A Alpuente, VJ Gallardo, L Asskour, E Caronna… - …, 2022 - journals.sagepub.com
Background CGRP plays a key role in the transmission and modulation of nociceptive signals
and is a critical component in the pathogenesis of migraine. Objective To assess saliva as …
and is a critical component in the pathogenesis of migraine. Objective To assess saliva as …
Patterns of response to anti‐calcitonin gene‐related peptide monoclonal antibodies during first 6 months of treatment in resistant migraine patients: Impact on outcome
M Torres‐Ferrus, VJ Gallardo… - European Journal of …, 2023 - Wiley Online Library
Background and purpose The response pattern to monoclonal antibodies against calcitonin
gene‐related peptide (anti‐CGRP MAbs) shown in migraine prevention clinical trials is not …
gene‐related peptide (anti‐CGRP MAbs) shown in migraine prevention clinical trials is not …
Partial and nonresponders to onabotulinumtoxinA can benefit from anti‐CGRP Monoclonal antibodies preventive treatment: a real‐world evidence study
A Alpuente, VJ Gallardo, E Caronna… - European Journal of …, 2021 - Wiley Online Library
Background and purpose Monoclonal antibodies targeting CGRP or its receptor, anti‐CGRP
mAbs, are proven to be effective treatments in migraine prevention. Real‐world evidence …
mAbs, are proven to be effective treatments in migraine prevention. Real‐world evidence …
[HTML][HTML] In search of a gold standard patient-reported outcome measure to use in the evaluation and treatment-decision making in migraine prevention. A real-world …
A Alpuente, VJ Gallardo, E Caronna… - The Journal of …, 2021 - Springer
Background Patient-Reported Outcomes (PROs) have been developed to numerically quantify
disability, impact and quality of life. They have been widely used in migraine clinical trials. …
disability, impact and quality of life. They have been widely used in migraine clinical trials. …
[HTML][HTML] Cortical metabolic and structural differences in patients with chronic migraine. An exploratory 18FDG-PET and MRI study
M Torres-Ferrus, D Pareto, VJ Gallardo… - The Journal of …, 2021 - Springer
… Victor J Gallardo … Pareto D, Cubera-Borrós G and Gallardo VJ contributed to analysis and
interpretation of data. Torres-Ferrus M wrote first draft. Alpuente A, Caronna C, Vila-Balló A, …
interpretation of data. Torres-Ferrus M wrote first draft. Alpuente A, Caronna C, Vila-Balló A, …
